Ignite Creation Date:
2025-12-24 @ 5:48 PM
Ignite Modification Date:
2026-06-07 @ 10:44 AM
Study NCT ID:
NCT06184568
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-17
First Post:
2023-12-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study Comparing IBI362 vs Semaglutide in Chinese Adults With Early Type 2 Diabetes and Obesity
Sponsor:
Innovent Biologics (Suzhou) Co. Ltd.
Organization: